First Time Loading...
A

Apogee Therapeutics Inc
NASDAQ:APGE

Watchlist Manager
Apogee Therapeutics Inc
NASDAQ:APGE
Watchlist
Price: 41.14 USD -4.59% Market Closed
Updated: Jun 15, 2024
Have any thoughts about
Apogee Therapeutics Inc?
Write Note

Apogee Therapeutics Inc
Cash from Investing Activities

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Apogee Therapeutics Inc
Cash from Investing Activities Peer Comparison

Comparables:
ABBV
GILD
AMGN
VRTX
REGN

Competitive Cash from Investing Activities Analysis
Latest Figures & CAGR of Competitors

Company Cash from Investing Activities CAGR 3Y CAGR 5Y CAGR 10Y
A
Apogee Therapeutics Inc
NASDAQ:APGE
Cash from Investing Activities
-$273.9m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Abbvie Inc
NYSE:ABBV
Cash from Investing Activities
-$11.1B
CAGR 3-Years
34%
CAGR 5-Years
-80%
CAGR 10-Years
-23%
Gilead Sciences Inc
NASDAQ:GILD
Cash from Investing Activities
-$3.6B
CAGR 3-Years
39%
CAGR 5-Years
N/A
CAGR 10-Years
-84%
Amgen Inc
NASDAQ:AMGN
Cash from Investing Activities
-$27.8B
CAGR 3-Years
-72%
CAGR 5-Years
N/A
CAGR 10-Years
-10%
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Cash from Investing Activities
-$3.4B
CAGR 3-Years
-705%
CAGR 5-Years
-69%
CAGR 10-Years
-57%
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
Cash from Investing Activities
-$4.6B
CAGR 3-Years
-89%
CAGR 5-Years
-21%
CAGR 10-Years
-26%

See Also

What is Apogee Therapeutics Inc's Cash from Investing Activities?
Cash from Investing Activities
-273.9m USD

Based on the financial report for Dec 31, 2023, Apogee Therapeutics Inc's Cash from Investing Activities amounts to -273.9m USD.